Dr. Rita Tanios is a pathologist with specialty focus in clinical pathology.
She completed her medical degree at the Lebanese University after which she did her clinical pathology training at the American University of Beirut. She then moved to Dubai where she worked with a leading independent provider for medical laboratory testing services for 3 years. After which she spent two years earning her masters degree in Molecular Biology at the Lebanese American University as well as another masters degree in Hospital Management from Ecole Superieure des affaires & Paris VII. In 2014, she moved to Abu Dhabi where she established a laboratory that was mainly focused on aiding in management of women’s health issues.
She has developed a special interest in laboratory accreditation, including both the CAP and ISO- 15189, which has aided her in starting several labs across the region.
Tanios R, Bekdash A, Kassab E, Stone E, Georgiou G, Frankel A, Abi-Habib R. Human recombinant arginase I(Co)-PEG5000[HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells. Leuk Res. 2013 Nov;37(11):1565-71
Mahfouz RA, Charafeddine KM, Tanios RF, Karaky NM, Abdul Khalik RN, Daher RT. Apolipoprotein E gene polymorphisms in Lebanese with hypercholesterolemia. Gene. 2013 Jun10;522(1):84-8
Kfoury-Baz EM, Nassar RA, Tanios RF, Otrock ZK, Youssef AM, Albany C, Bazarbachi A, Salem ZM. Plasmapheresis in asparaginase-induced hypertriglyceridemia. Transfusion. 2008, Jun;48(6):1227-30
In reply: Kfoury-Baz EM, Nassar RA, Tanios RF, Otrock ZK, Youssef AM, Albany C, Bazarbachi A, Salem ZM. Transfusion, January 2009.
Yunis K, Tanios R. A Neonatal Screening program in beirut, lebanon: results of Ten years Experience. Hot Topics in neonatology, vermont Oxford network Annual meeting, Washington DC, December 2006 (Poster)
Abi-Habib RJ, Tanios R, Bekdash A, Kassab E, Stone E, Geogiou G and Frankel AE. Sensitivity of Human Acute Myeloid Leukemia Cells to a Recombinant Human Arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]. To be presented at the annual American Society of Cell Biology Meeting in San Francisco, California, December 15-19, 2012
Tanios R, Bekdash A, Kassab E, Stone E, Geogiou G, Frankel AE and Abi-Habib RJ. Sensitivity of Human Acute Myeloid Leukemia Cells to Human Recombinant Arginase I (Co)-PEG5000 [HuArgI(Co)-PEG5000]-Induced Arginine Depletion. Presented at the annual meeting of the European Molecular Biology Organization (EMBO) in Nice, France, September 22-25, 2012.
Abi-Habib RJ, Bekdash A, Tanios R, Kassab E, Stone E, Georgiou G, Frankel AE. Human Recombinant Arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000] is Selectively Cytotxic to Human Acute Myeloid Leukemia (AML) Cell Lines. Presented at the Third Symposium on Targeted Tumor Therapies in Berlin, Germany, March 21-23, 2012